Brain Cancer News and Research

RSS

There are two main types of brain cancer. Primary brain cancer starts in the brain. Metastatic brain cancer starts somewhere else in the body and moves to the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Also called glioma, meningioma.

Arsenic trioxide could be powerful therapy to extend lives of certain glioblastoma patients

From Sherlock Holmes to Agatha Christie, arsenic is often the poison of choice in popular whodunits. But in ultra-low dosage, and in the right form, this naturally occurring chemical element can be a potent force against cancer.

17 Oct 2017

Scientists receive critical funding to study treatments for three deadly cancers

Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the deadliest forms of cancer: glioblastoma (brain cancer), sarcoma (bone cancer) and ovarian cancer.

17 Oct 2017

Using AFM to study cell mechanics and function

My lab, broadly speaking, is interested in trying to understand interactions between cells and materials. Those could be materials that are present within living tissue or materials that we use for engineering purposes to try to do something of technological or therapeutic interest.

From Bruker Nano Surfaces and Metrology 17 Oct 2017

CHOP researchers discover key differences among gene fusions in childhood brain tumors

Researchers investigating pediatric low-grade gliomas, the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood cancer.

17 Oct 2017

Wake Forest Baptist scientists win grant to develop more effective treatments for brain cancer

Glioblastoma is the most aggressive cancer that originates in the brain. Current therapies can slow the disease, but more often than not can't cure it.

16 Oct 2017

Researchers to investigate cellular changes leading to development of glioblastoma

Glioblastoma is the most common of malign brain tumors in adults, and it currently has no cure. Now a research team led by Dr Claudia Barros, from the Plymouth University Peninsula Schools of Medicine and Dentistry and its Brain Tumour Research-funded Centre of Excellence, has secured funding from the Brain Research Trust, which will help to expose novel molecules and their modes of action responsible for the initiation and growth of the disease.

16 Oct 2017

Scientists validate biomarker indicative of brain cancer patient's prognosis and drug response

Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions including Colorado State University and Fred Hutchinson Cancer Center reported results today from a glioblastoma study in which they validated a biomarker indicative of a patient's prognosis and likely response to specific therapies.

16 Oct 2017

Research finds higher rates of cancer in world's ‘better’ countries

The world's "better" countries, with greater access to healthcare, experience much higher rates of cancer incidence than the world's "worse off" countries, according to new research from the University of Adelaide.

11 Oct 2017

UCLA scientists discover potential combination treatment for brain cancer in adults

UCLA scientists have discovered a potential combination treatment for glioblastoma, the deadliest form of brain cancer in adults. The three-year study led by Dr. David Nathanson, a member of UCLA's Jonsson Comprehensive Cancer Center, found that the drug combination tested in mice disrupts and exploits glucose intake, essentially cutting off the tumor's nutrients and energy supply.

9 Oct 2017

RCSI-led study aims to train next generation of brain cancer researchers

RCSI is leading an international team of scientists on a major research study that aims to train the next generation of brain cancer researchers.

3 Oct 2017

Study opens new door to potential treatments for highly lethal brain tumors

New research conducted in mice provides evidence that highly lethal brain tumors, called high-grade gliomas, stop growing when deprived of a specific molecule naturally produced when brain cells fire.

21 Sep 2017

Poliovirus therapy triggers longer-lasting immune response against malignant tumors

An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells to evade the immune system.

20 Sep 2017

Researchers develop new model to better simulate blood brain barrier for study of diseases

Scientists have helped provide a way to better understand how to enable drugs to enter the brain and how cancer cells make it past the blood brain barrier. The brain is protected by the near-impermeable blood brain barrier, a fortress which protects the brain but which also prevents the treatment of brain diseases, including brain tumors.

19 Sep 2017

Patients diagnosed with glioblastoma benefit from care at high-volume centers, study suggests

Patients diagnosed at high-volume centers are up to 40 percent more likely to receive treatment for glioblastoma, according to a study from researchers at the University of Illinois at Chicago.

14 Sep 2017

Japanese researchers find new way for increasing effectiveness of drug delivery to brain tumors

For a cancer drug to be successful, it needs to reach the malignant tumor site. Researchers in Japan have now found a way for increasing the effectiveness of drug delivery to certain types of brain tumors, by packing epirubicin, a known antitumor agent, in specially designed polymeric micelles.

13 Sep 2017

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

An International Journal of Cancer study found that female survivors of certain types of cancer have higher risks of poor outcomes in pregnancies conceived after diagnosis than women without cancer.

12 Sep 2017

Zika virus found to specifically kill glioblastoma brain cancer cells

According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.

5 Sep 2017

Brain Cancer News and Research

Further Reading

Arsenic trioxide could be powerful therapy to extend lives of certain glioblastoma patients

Scientists receive critical funding to study treatments for three deadly cancers

Using AFM to study cell mechanics and function

CHOP researchers discover key differences among gene fusions in childhood brain tumors

Wake Forest Baptist scientists win grant to develop more effective treatments for brain cancer

Researchers to investigate cellular changes leading to development of glioblastoma

Scientists validate biomarker indicative of brain cancer patient's prognosis and drug response

Research finds higher rates of cancer in world's ‘better’ countries

UCLA scientists discover potential combination treatment for brain cancer in adults

RCSI-led study aims to train next generation of brain cancer researchers

Study opens new door to potential treatments for highly lethal brain tumors

Poliovirus therapy triggers longer-lasting immune response against malignant tumors

Researchers develop new model to better simulate blood brain barrier for study of diseases

Patients diagnosed with glioblastoma benefit from care at high-volume centers, study suggests

Japanese researchers find new way for increasing effectiveness of drug delivery to brain tumors

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Zika virus found to specifically kill glioblastoma brain cancer cells

Zika virus may one day be effective treatment for deadly brain cancer

Study sheds new light on gene fusion in bladder and brain cancer

CSUDH professor seeks novel lead compound to develop new drug for treating cancer

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News